FREE Account Opening + No Clearing Fees
Loading...
May 27, 2008 - May 30, 2008

Bafna Pharmaceuticals IPO Latest News Today

Track all the latest updates and news of Bafna Pharmaceuticals IPO.

  1. Health care company with big Philadelphia-area presence seeks up to $585M in IPO

    July 16, 2024 8:11:00 PM

    J.P. Morgan, Goldman Sachs & Co. and BofA Securities are lead book-running managers for the IPO. Deutsche Bank Securities, Wells Fargo Securities, Mizuho, RBC Capital Markets and Truist Securities are ...

    Published by : The Business Journals
  2. U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week

    July 20, 2024 12:20:00 PM

    A handful of IPOs priced this past week, led by three sizable names. One large issuer joined both the pipeline and the calendar - Chile-based LATAM Airlines Group.

    Published by : Seeking Alpha
  3. Emcure Pharmaceuticals IPO allotment out: Heres how to check status online

    July 8, 2024 9:58:00 PM

    Those who have invested in Emcure Pharmaceuticals IPO can check their allotment status online via the official websites of BSE and issue�s registrar. Emure Pharmaceuticals IPO is set to release ...

    Published by : Hindustan Times
  4. Emcure Pharmaceuticals IPO Opens Tomorrow: Heres How Much Shark Tanks Namita Thapar Expected To Earn

    July 2, 2024 1:43:05 PM

    E mcure Pharmaceuticals is set to open its initial public offering (IPO) for subscription on Wednesday, July 3. Before the listing, the company's shares were trading at a premium of Rs 265 in the ...

    Published by : Times Now on MSN
  5. Emcure Pharma IPO to open today

    July 3, 2024 2:12:00 PM

    Shark Tank fame Namita Thapar likely to make around Rs 127 crore through Emcure Pharmaceuticals IPO Emcure Pharmaceuticals' FY 2024 revenue grew by 11% to Rs 6,658 crore, with profits at Rs 527 crore.

    Published by : Indiatimes
  6. Emcure Pharmaceuticals IPO: 10 key risks investors should consider before subscribing to the 1,952-crore issue

    July 4, 2024 12:39:00 AM

    Emcure Pharmaceuticals IPO price band has been set in the range of ?960 to ?1,008 per equity share of the face value of ?10. (https://www.emcure.com/) Emcure ...

    Published by : Mint
  7. Emcure Pharmaceuticals IPO debuts tomorrow: All you need to know ahead of listing

    July 10, 2024 1:08:00 AM

    Emcure Pharmaceuticals IPO listing: Ahead of the listing, Emcure Pharma IPO GMP is +352 which indicates that the company's share price was trading at a premium. Emcure Pharmaceuticals IPO listing ...

    Published by : Hindustan Times
  8. Emcure Pharmaceuticals IPO opens today

    July 3, 2024 3:50:00 PM

    The initial public offering of Emcure Pharmaceuticals Ltd begins for subscriptions today July 3, 2024. The IPO, backed by Bain Capital, has a price band set between ?960 and ?1,008 per share ...

    Published by : India Infoline
  9. Emcure Pharmaceuticals IPO subscription details on day 2

    July 4, 2024 3:56:00 PM

    Emcure Pharmaceuticals Ltd�s IPO, opened on July 3. The ?1,952-Crore IPO closes on July 5 and has received an overall subscription of 2.48 times at the time of writing on July 4, 2024 at 12:18 ...

    Published by : India Infoline
  10. Emcure Pharmaceuticals IPO listing tomorrow: Here�s what GMP, subscription status indicate ahead of listing

    July 9, 2024 11:28:00 PM

    Emcure Pharmaceuticals IPO listing date has been scheduled for tomorrow (Wednesday, July 10). (https://www.emcure.com/) Emcure Pharmaceuticals IPO listing date has ...

    Published by : Mint

Bafna Pharmaceuticals IPO Alerts

1. Bafna Pharmaceuticals Ltd IPO - Listing  Friday, June 27, 2008 12:00:00 AM

Bafna Pharmaceuticals Ltd IPO Listing Info

IPO Listing Date: Friday, June 27, 2008
BSE Script Code: 532989
Listing in: B Group of securities
ISIN: INE878I01014
Issue Price: Rs. 40/-
Face Value: Rs 10/- Per Equity Share

2. Bafna Pharmaceuticals Ltd IPO Listing Info  Thursday, June 26, 2008 9:14:00 AM

Bafna Pharmaceuticals Ltd IPO Listing Info:

IPO Listing Date: Friday, June 27, 2008
BSE Script Code: 532989
Listing in: B Group of securities
ISIN: INE878I01014
Issue Price: Rs. 40/-
Face Value: Rs 10/- Per Equity Share

3. Bafna Pharmaceuticals Ltd IPO Allotment  Saturday, June 21, 2008 8:48:00 AM

IPO Allotment Status is now available online for Bafna Pharmaceuticals Ltd IPO.

Issue was fixed price and will only list on BSE. Listing date will be available soon.

4. Bafna Pharmaceuticals Ltd IPO - Allotment  Saturday, June 21, 2008 12:00:00 AM

IPO Allotment Status is now available online for Bafna Pharmaceuticals Ltd IPO.

Issue was fixed price and will only list on BSE. Listing date will be available soon.

5. Bafna Pharmaceuticals Limited - Close  Friday, May 30, 2008 12:00:00 AM

Incorporated in 1995, Bafna Pharmaceuticals Limited is engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.

Bafna Pharmaceuticals Limited is entering in the capital markets with an initial public offering, IPO of 64,00,000 Equity Shares for cash, at the premium of Rs 30.

The price band for the issue has been fixed at Rs. 40/- for equity share of Rs. 10/-. The issue opens on May 27, 2008, and closes for subscription on May 30, 2008. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

6. Bafna Pharmaceuticals Limited - Open  Tuesday, May 27, 2008 12:00:00 AM

Incorporated in 1995, Bafna Pharmaceuticals Limited is engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.

Bafna Pharmaceuticals Limited is entering in the capital markets with an initial public offering, IPO of 64,00,000 Equity Shares for cash, at the premium of Rs 10.

The price band for the issue has been fixed at Rs. 40/- for equity share of Rs. 30/-. The issue opens on May 27, 2008, and closes for subscription on May 30, 2008. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

7. Bafna Pharmaceuticals Limited IPO Opening on May 27  Sunday, May 18, 2008 12:45:00 PM

Incorporated in 1995, Bafna Pharmaceuticals Limited is engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.

Bafna Pharmaceuticals Limited is entering in the capital markets with an initial public offering, IPO of 64,00,000 Equity Shares for cash, at the premium of Rs 30.

The price band for the issue has been fixed at Rs. 40/- for equity share of Rs. 10/-. The issue opens on May 27, 2008, and closes for subscription on May 30, 2008. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

Bafna Pharmaceuticals IPO News & Events FAQs

The Bafna Pharmaceuticals IPO is proposed to open on May 27, 2008. The IPO application ends on May 30, 2008.

Retail investors can apply in the retail or non-institutional investor category from May 27, 2008 to May 30, 2008. The Bafna Pharmaceuticals IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Bafna Pharmaceuticals IPO will open for subscription on May 27, 2008. The public issue will close on May 30, 2008.